Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?

Research output: Contribution to journalArticlepeer-review

Abstract

This study aims to analyze the outcome of patients with stage IIIA-N2 non–small-cell lung cancer who underwent pneumonectomy to prove its safety and feasibility, in particular after induction chemotherapy. Based on the acceptable morbidity and mortality rate and the long-term survival, pneumonectomy should not be excluded for selected patients as a matter of principle.

Original languageEnglish
Pages (from-to)97-106.e1
JournalClinical Lung Cancer
Volume20
Issue number2
DOIs
Publication statusPublished - Mar 2019

Keywords

  • Advanced stage
  • Induction therapy
  • Lung cancer
  • Short and long term outcomes
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint

Dive into the research topics of 'Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?'. Together they form a unique fingerprint.

Cite this